LRMR vs. RCAT

Last updated Jun 24, 2026

LRMR (Larimar Therapeutics, Inc.) and RCAT (Red Cat Holdings, Inc.) are both stocks. LRMR operates in Biotechnology (Healthcare), while RCAT operates in Aerospace & Defense (Industrials). Over the past 5 years, LRMR returned -15.85%/yr vs 31.69%/yr for RCAT. At a 0.11 correlation, their price movements are largely independent.

Performance

LRMR vs. RCAT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Larimar Therapeutics, Inc. (LRMR) and Red Cat Holdings, Inc. (RCAT). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, LRMR achieves a -3.41% return, which is significantly lower than RCAT's 28.37% return.

LRMR

• 1D: 0.55%
• 1M: 6.67%
• YTD: -3.41%
• 6M: -5.88%
• 1Y: 52.07%
• 3Y*: 3.60%
• 5Y*: -15.85%
• 10Y*: -25.54%

RCAT

• 1D: -4.23%
• 1M: 8.18%
• YTD: 28.37%
• 6M: 10.89%
• 1Y: 41.78%
• 3Y*: 105.10%
• 5Y*: 31.69%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

LRMR vs. RCAT - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019
LRMR Larimar Therapeutics, Inc.	-3.41%	-1.55%	-14.95%	10.17%	-61.72%	-49.60%	60.74%	7.77%
RCAT Red Cat Holdings, Inc.	28.37%	-38.29%	1,360.23%	-6.38%	-54.81%	-30.67%	172.73%	-73.81%

Correlation

The correlation between LRMR and RCAT is 0.17, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.17
Correlation (3Y) Calculated over the trailing 3-year period	0.11
Correlation (5Y) Calculated over the trailing 5-year period	0.12
Correlation (All Time) Calculated using the full available price history since Aug 2, 2019	0.11

Fundamentals

EPS LRMR : -$2.92 RCAT : -$0.78
Total Revenue (TTM) LRMR : $0.00 RCAT : $52.98M
Gross Profit (TTM) LRMR : -$87.00K RCAT : $2.86M
EBITDA (TTM) LRMR : -$170.38M RCAT : -$79.24M

Return for Risk

LRMR vs. RCAT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

LRMR

LRMR Risk / Return Rank: 65
LRMR Sharpe Ratio Rank: 59
LRMR Sortino Ratio Rank: 70
LRMR Omega Ratio Rank: 69
LRMR Calmar Ratio Rank: 65
LRMR Martin Ratio Rank: 62

RCAT

RCAT Risk / Return Rank: 59
RCAT Sharpe Ratio Rank: 55
RCAT Sortino Ratio Rank: 65
RCAT Omega Ratio Rank: 60
RCAT Calmar Ratio Rank: 58
RCAT Martin Ratio Rank: 57

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

LRMR vs. RCAT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Larimar Therapeutics, Inc. (LRMR) and Red Cat Holdings, Inc. (RCAT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	LRMR	RCAT	Difference
Sharpe ratio: Return per unit of total volatility	0.47	0.35	+0.11
Sortino ratio: Return per unit of downside risk	1.66	1.43	+0.23
Omega ratio: Gain probability vs. loss probability	1.21	1.16	+0.05
Calmar ratio: Return relative to maximum drawdown	1.09	0.70	+0.39
Martin ratio: Return relative to average drawdown	2.04	1.39	+0.66

LRMR vs. RCAT - Sharpe Ratio Comparison

The current LRMR Sharpe Ratio is 0.47, which is higher than the RCAT Sharpe Ratio of 0.35. The chart below compares the historical Sharpe Ratios of LRMR and RCAT, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

LRMR vs. RCAT - Drawdown Comparison

The maximum LRMR drawdown since its inception was -99.75%, which is greater than RCAT's maximum drawdown of -92.25%. Use the drawdown chart below to compare losses from any high point for LRMR and RCAT.

Drawdown Indicators

	LRMR	RCAT	Difference
Max Drawdown Largest peak-to-trough decline	-99.75%	-92.25%	-7.50%
Max Drawdown (1Y) Largest decline over 1 year	-47.90%	-60.08%	+12.18%
Max Drawdown (3Y) Largest decline over 3 years	-87.12%	-67.16%	-19.96%
Max Drawdown (5Y) Largest decline over 5 years	-89.87%	-92.25%	+2.38%
Max Drawdown (10Y) Largest decline over 10 years	-98.94%	—	—
Current Drawdown Current decline from peak	-99.40%	-41.36%	-58.04%
Average Drawdown Average peak-to-trough decline	-86.65%	-62.25%	-24.40%
Ulcer Index Depth and duration of drawdowns from previous peaks	25.54%	30.16%	-4.62%

Volatility

LRMR vs. RCAT - Volatility Comparison

The current volatility for Larimar Therapeutics, Inc. (LRMR) is 18.88%, while Red Cat Holdings, Inc. (RCAT) has a volatility of 42.36%. This indicates that LRMR experiences smaller price fluctuations and is considered to be less risky than RCAT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	LRMR	RCAT	Difference
Volatility (1M) Calculated over the trailing 1-month period	18.88%	42.36%	-23.48%
Volatility (6M) Calculated over the trailing 6-month period	71.85%	85.19%	-13.34%
Volatility (1Y) Calculated over the trailing 1-year period	112.30%	118.75%	-6.45%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	95.98%	114.59%	-18.61%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	88.97%	165.18%	-76.21%

Dividends

LRMR vs. RCAT - Dividend Comparison

Neither LRMR nor RCAT has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both LRMR and RCAT in my portfolio?

LRMR and RCAT have a correlation of 0.17, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, LRMR or RCAT?

RCAT has higher volatility (42.36%) compared to LRMR (18.88%). In terms of maximum drawdown, LRMR dropped -99.75% vs RCAT's -92.25%.

Which has better risk-adjusted returns?

LRMR currently has the higher Sharpe Ratio (0.47 vs 0.35), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.